Traws Pharma, Inc.TRAWNASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank71
3Y CAGR+135.7%
5Y CAGR+66.5%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+135.7%/yr
vs -34.5%/yr prior
5Y CAGR
+66.5%/yr
Recent acceleration
Acceleration
+170.2pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
12.8x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$2.96M+1209.3%
2024$226000.000.0%
2023$226000.000.0%
2022$226000.000.0%
2021$226000.00-2.2%
2020$231000.00-89.4%
2019$2.18M+77.8%
2018$1.23M+56.0%
2017$787000.00-85.8%
2016$5.55M-